SilverCoat's coating technology gives an unsurpassed level of confidence because it utilizes an advanced, patented surface modification process that permanently binds with the catheter at the monomer level for improved functionality and performance.
* Covalon Technologies data on file. All trademarks are the property of their respective owners
A urinary tract infection (UTI) is an infection involving any part of the urinary system, including urethra, bladder, ureters, and kidney. Among UTIs acquired in the hospital, approximately 75% are associated with a urinary catheter, which is a tube inserted into the bladder through the urethra to drain urine. Between 15-25% of hospitalized patients receive urinary catheters during their hospital stay. The most important risk factor for developing a catheter-associated UTI (CAUTI) is prolonged use of the urinary catheter. Source:CDC
SilverCoat is only available by prescription or directly through a hospital or clinic. Your doctor may be able to source from their existing supplier, or they can contact us for more information.
SilverCoat is available through medical distributors. If your distributor does not carry SilverCoat, please contact us for distributor names or for more information.
If you would like to distribute SilverCoat, please contact us for information. Download the brochure.
SilverCoat™ Antimicrobial Silicone Foley Catheter - Confidence in the Coating makes the Difference.
FDA Clearance Pending. Not for sale in U.S.A.
May 15, 2013Arab Health Magazine features SurgiClear article: The importance of wound dressings.
May 01, 2013Covalon’s ColActive Plus Receives Medicare Billing Codes in Advance of the Symposium on Advanced Wound Care in Denver